ArticleDrug and alcohol dependence2025
World Health Organization risk drinking level reductions as treatment outcomes in PTSD and substance use disorder trials.
Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
objectiveAlcohol use disorder (AUD) clinical trials have traditionally prioritized abstinence, and more recently, heavy drinking cessation as primary treatment endpoints. Reductions in World Health Organization (WHO) risk drinking levels may offer a viable harm reduction-aligned alternative. Despite evidence supporting WHO risk level reductions as meaningful indicators of AUD treatment response, their utility in individuals with co-occurring posttraumatic stress disorder (PTSD) remains unknown. The present study compared 1- and 2-level WHO risk drinking reductions with abstinence and heavy drinking (HD) outcomes, and assessed their sensitivity across PTSD and substance use disorder (SUD) interventions, including behavioral and pharmacological treatments.
methodsWe conducted an integrative data analysis of 10 trials for adults with comorbid PTSD and SUD (PTSD+SUD). The proportion of participants achieving each of the four alcohol outcomes was calculated. Logistic regression models assessed treatment effects relative to treatment as usual (TAU).
resultsAcross the 10 trials (N = 433; mean [SD] age, 39.7 [11.6] years; 359 [73.0 %] men), the most frequently achieved drinking outcome at end-of-treatment was a 1 + level WHO risk reduction (82.8 %), followed by a 2 + level reduction (72.2 %), HD cessation (65.6 %) and, least frequently, abstinence (53.0 %). Pharmacological interventions significantly outperformed TAU across all drinking outcomes.
conclusionsFindings provide initial support for WHO risk drinking levels as viable endpoints in PTSD+SUD trials. Given their attainability, WHO risk levels may provide clinically relevant outcome metrics for these interventions. Future research should assess whether such reductions correspond to improvements in alcohol-related harms and broader functional outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.